Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australian Senate panel does not ban gene patenting; new bill may prohibit practice

This article was originally published in RAJ Devices

Executive Summary

The Australian Senate committee that is looking into the impact of gene patents on healthcare and medical research has stopped short of recommending an express prohibition on the patenting of genes1,2. It has instead suggested numerous reforms to improve the quality of patents and the operation of the patent system in general, to ensure that a patent is granted only where an invention is "sufficiently novel, inventive and useful".




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts